host: the fda, there has been a proposal to reorganize the food program at fda to change how they handle that and even taking food out of the fda's mission. explain. guest: the reorganization is fine. who needs to be there. there is years of history about food in the food fda. nutrition needs to be a priority and that is of value of the fda so improvements in the structure and elevating food and private partnerships, there are number of ways but i would not take food out of the mission. host: we are talking about the responsibilities and major health challenges, the infant formula storage, we want to hear from you. phone lines regionally (202) 748-8000 nav eastern or central time zones. if you are in the mountain road -- or pacific time zones, (202) 748-8001. what does the biden administration went to see it comes to the cdc and the fda specifically? guest: we will wait and see. they haven't officially announced they are doing a internal review. i think the fda is the same way but i want to also make a point that we talk about this federal leadership and coordination that is required but

you will hear from fda commissioner, the cdc director, and myself. next to me we have the deputy coordinator of the white house monkeypox response and dr. peter marx from fda and the hhs assistant secretary for preparedness response here to answer some questions. with that, i will turn it over to secretary becerra. >> thanks very much. let me begin with what up before. every american should take epoque seriously, and every american must do their part to help us combat monkeypox. on may 18, the first case of monkeypox was reported in the u.s. today we have some in on hundred cases that have been reported. -- 8900 cases reported. within two days, we began to ship out vaccines to the states ever asking for help. today we have made more than 1.1 million vaccine doses available throughout the country and we have delivered more than 620 thousand of those doses. we have also deployed more than 15,000 courses and increase the countries capacity to administer tests on a weekly basis. last week i declared a public health emergency to address the monkeypox outb

and that is also the fda. improvements in the structure, elevating food, partnerships, there are a number of ways, but i would not take food out of the fda mission. john: dr. anand parekh is with us until 8:45 east of this morning, talking about the federal response to major health challenges, whether monkeypox, covid, the infant formula shortage. phone lines are split regionally in this segment, host: if you are in -- (202) 748-8000 four eastern and central time zones, and others, (202) 748-8001. we have gotten proposals on these issues from folks here in washington, what does the binding administration want when it comes to the cdc and fda? dr. parekh: i think we want to wait and see. they haven't officially announced they are doing an internal review of how cdc should improve internal operations. i think the fda needs to deal with it the same way. but we are talking a lot about the federal leadership and coordination that is required, but there is a really important flipside. you can have the best federal r

do we want to start with fda on that? >> i will answer this pretty quick. if you got your first dose subcutaneous, the second dose can be given intradermally, and that is our recommendation. just make it simple and straightforward, the immunologic response should be the same. dr. walensky may want to talk about the logistics of that. >> i would just add that for those who have delayed their second dose, we would encourage them now with the resupply to go ahead and get it so that they can have a quicker path to protection. >> just commenting on the last question about eligibility, this is potentially also a question for dr. walensky. current eligibility remains the same as vaccine supply increases so there is not a change there yet. >> with that, i want to start at -- end where i started, which is, this is a significant priority of not only the president and this administration to make sure that we are working across all government and with all communities to make the whole government process here to make sure that we work as quick as possible to control, co

guest: on the first issue of fda approving particular drugs. i agree that hydroxychloroquine should have received authorization. in terms of preventing severe illness, vaccines are the best that we have. there is a terrific track record there in terms of preventing severe illness. there are other factors, these cloth based mass are not doing much of anything. n95 masks are important. in terms of the trust of these federal agencies, i don't think any agency has gotten everything right. when you look retrospectively, i am sure there are a lot of things these agencies would've done differently. at their core, these agencies have public servants that are trying to do the right thing. we have to make sure we don't lose faith in these agencies. most of the time, they get things right sometimes they get things wrong. i do agree with you that there is a trust problem and we need to work on that. i think that is something with the american public and the agencies, improve messaging, i think the take away is we need renew trust and build that trust up. h

the real expense is the clinical trial it takes to get through the fda process. host: lesko to richard in new jersey. independent line. caller: my point is this. in our country, corporate america runs every. corporate america is making big profit -- profits and do not make -- pay taxes but make a big prices. as customers are complaining of the government does not do this or the president does not support people but corporate america is why the prices have gone up. you have the whole issue with inflation but look at corporate america. corporate america has reduced the costs and all these corporations are putting factories out of the country. yet, they are buying products to make and sell to us at very low price. there is no reason which should be paying -- we should be paying for drugs. medicare should be negotiating prices of prescription drugs and the government should come down on corporate america. the price of oil went up to five dollars in new jersey where over five dollars. the oil was already in the pipeline and the system. host: we will hold us there and

we should have a law of confidence the fda is doing its job in the right way. i have criticized the fda on this program from being a bit too conservative or too cautious, creating higher costs, when it comes to clinical trials and making sure they are safe, the fda does a pretty good chop most of the time and i think we can have confidence in their work. host: -- declaring a public health emergency on monkeypox. is that a good movie? guest: no. there is a lot of fatigue from public health emergencies. i think they could have done a better job by saying this is something to be concerned about, here are the risks. two x and y to minimize reduction. i think there are a lot of people in the public health committee who think that if less -- that unless you terrify people, they will not do things like wear and mask. the opposite is true. if you try to terrify people, it is like the boy who cried will sexual. host: avik roy from the foundation of research on equal opportunity. the president has the pennsylvania for a speech on crime and safety. he will travel on labor

i'll make you the head of the cdc and the fda right now. what's the one thing you're going to do that you wish they would do right now? >> i think, really, we have to focus on two things. it is tough to have a laundry list of things. the two things are really vaccinations and packs loaded. you can help vaccinated and unvaccinated folks. different strokes for different folks. all with the goal of helping people not get very, very ill. >> we appreciate the inside. i'm going to take the promotion back. you can go about your day job now. >> thanks so much. >> take care. >>> a fight in a gym in contra costa county turned into a shoot out in the parking lot. we are now learning who people think is responsible. football is back. we are live at levi stadium tonight as 49ers fans are getting ready for game one of the preseason. >> beautiful weather for football. we've got 80s in dublin. get ready. ocean air conditioning about to go away this weekend. >>> new details tonight on a deadly shootout in an east bay gym. a teenager has been arrested for sh

they did that with fda approval and now the fda is threatening some companies for recalls and fines for the same sanitizer they approved. cal wine spirits in california one such distillery. they're not taking this lying down. so what gives the fda the right to come back at the companies that helped save us all in 2020? here with me now, is founder of cal wine spirits in california, aaron berg, welcome, aaron. >> thanks for having me, kennedy. kennedy: in 2020, you're trying to do your part and keep your company up and running and like we have alcohol, they need alcohol, you start making sanitizer, and they wanted to fine you for it back then. what is going on now? aaron: well, i thought it would all be over after 2020 and tried to fine us and that didn't go well for them, but after they took samples 18 minnesotas ago, they said your hand sanitizer has an impurity called fee al aldehyde and we need to audit your records again and we need you to recall it and we might issue a fine and it's a big mess now, which doesn't make any sense. if it is a a problem, when i don't believe the fda tru

cibinqo — fda approved. 100% steroid free. not an injection, cibinqo is a once-daily pill for adults who didn't respond to previous treatments. and cibinqo helps provide clearer skin and less itch. cibinqo can lower your ability to fight infections, including tb. before and during treatment, your doctor should check for infections and do blood tests. tell your doctor if you've had hepatitis b or c, have flu-like symptoms, or are prone to infections. do not take with medicines that prevent blood clots. serious, sometimes fatal infections, lymphoma, lung, skin and other cancers, serious heart-related events, and blood clots can happen. people 50 and older with heart disease risk factors have an increased risk of serious heart-related events or death with jak inhibitors. this is the moment. but we've only just begun. speak with your doctor about cibinqo today. an innovation from pfizer. >>> next tonight here, we are tracking record-breaking heat across several states in the west tonight. temperatures hitting 110 to 116 degrees in

new suggested guidelines from the fda are different than what local health departments in california are recommending. our abc7news reporter has the details. >> home test kits are important to the new suggested guidelines issued by the fda. following a known exposure to someone with covid-19, even if you have absolutely no symptoms, the fda is now recommending three home tests be administered. testing when you find out, waiting several days in testing again on day three, and then again on day five. the new calculus from the fda reveals that two tests catch 60% of asymptomatic cases, three tests catch 80%. what to do as kids go back to school? using more home test kits is both expensive and difficult. >> for some families, this might not be ■feasible, it could be burdensome. it is the best way to prevent those who may have infection to expose others and prevent transmission, but it is a bit clumsy, it's not as simple as just doing one test. >> but the state of california has not changed their guidelines for how to respond if you have a covert exposure, even if you have no symptoms.

the fda has authorized novavax's covid vaccine for emergency use for adolescents between the ages of >> 12 17. just last month. the fda ok, the biotech company's 2 dose regimen for adults 18 and older company officials say they hope having more vaccine options for adults and kids will increase vaccination rates, especially with back to school here, a senior fda official says novavax's vaccine could potentially appeal to unvaccinated people who would prefer a shot. that is not based on the new mrna technology used by pfizer and moderna. >> former president trump's legal team asking a judge to stop the fbi from reviewing documents seized during the raid on mar-a-lago. in today's court filing, the attorneys say that the documents seized should be covered by executive privilege and they want a neutral special master appointed. the judge in this case is that he carefully review the fbi evidence and found it reliable. he's given the justice department until thursday to submit a redacted version of that affidavit. but the judge warned that that version could have somebody redactions that wo

the fda ordered vaccine makers to took their formula to target the ba 4 nba 5 variants. well, to be a 5 year. it is the cause of nearly all us covid infections right now, the u.s. has a contract to buy 105 million updated. pfizer doses as soon as health officials sign off on them. the government also has a contract of i-66 million doses of that mandate. it moderna updated vaccine. but moderna has asked regulators to approve an updated shot just yet. well, a south bay family is fighting back after their school remove their 4 year old from class because he was not wearing a face mask. well, the school says it was a necessity because of the community transmission levels coffers. amanda harry spoke to the family about why they decided to take legal action. >> we want to toys and and legally we're allowed to toys. so that's my hold my ground. a mountain view whisman school district family says their 4 year-old son wasn't allowed to attend school because he didn't want to wear a mask. father sean took this video on august 18th. >> when the district required all students and st

the fda authorized the new formula without waiting for results from clinical trials. but health experts argue the process is no different than what they do for other vaccines. vaccines. >> while we have little safety data it really is tested as we do it here. we think it's original enough to the original9 original covid-19 vaccine that it will be safe. make the cdc still needs to sign off, but once modified boosters are available the fda says you can get them at the same time as your annual flu shot. nancy chen, cbs news, new york. > >> chp is investigating a freeway shooting that left a 9-year-old boy injured. it happened before 10:00 last night night on hundred 80 in oakland for two vehicles were involved. the boy was on brookdale avenue. avenue. the female driver, also injured. she and the boy today are in stable condition. so far chp has not found a suspect or determined why the child was injured. > >> police are investigating a late night sexual assault. police and the victim got off the transit on university avenue avenue between 2:00 and 3:00, and the man sexua

pfizer asked the fda to approve its combo covid vaccine. this new vaccine targets the omicron sub variant. pfizer tweaked the vaccine to specifically target the ba .4 and ba .5 strains. it comes after the fda specifically asked for the change. if the fda authorizes the shots, they could be ready by mid september. moderna is also working on a similar shot and is expected to also ask the fda for approval. we are getting a better idea of how covid impacts us, long term. studies suggest that getting covid increases our risk of developing certain brain disorders. this comes from the university of oxford. it looks at health records for more than 1 million people around the world. those people had an increased risk of things like dementia, epilepsy, and brain fog. for two years after getting sick. joining us now, one of our infectious disease experts from ucsf. nice to have you back with us, doctor. to be clear, if i have covid, this report suggests i would in have an increased chance of brain disorders for two years after covid or long time after

pfizer is asking the fda for authorization for its new covid booster. moderna working on doing the same. the main difference with the newer pfizer covid booster versus the old one? the new one has been tweaked to go after the ba.4 and ba.5 strains and comes specifically is as the fda asked for the change. ba.5 is the dominant strain in the country, older vaccines are not as effective in preventing breakthrough infections with the omicron subvariant. this new booster targets just that, less infections, less chance there is that our winter months will be disrupted at school and at work. let's listen to the cdc director speaking on the new booster on the "today" show this morning. >> i would say there's never a bad time to go ahead and get your booster if you're eligible. if you're over the age of 50 and you haven't gotten that second booster, you can still go ahead and get it now. >> reporter: there is a caveat how quickly the new booster was developed. the fda is allowing pfizer to submit far less data on the shot than it did for previous vaccines. docto

now this extraordinary to think that these institutions were approved by the fda and the dea, fda is over the dea for clinical trials because they satisfied several important criteria. one unlikely to do any harm, two being able to address a critical medical need, that's not currently being addressed by conventional medicine. and three, is it scalable? can it be brought in as a medicine at an affordable price? so indeed these benchmarks have been met, there is now up to 40 institutions that are currently doing clinical studies on psilocybin. and even in europe, i think there's around, next slide if we could, we have about 20 institutions in europe also. so this is a global movement, which is astonishing about this is the course of conclusions all steer towards the same end points that these are some of the most powerful psychoactive, and psychiatric medicines ever been discovered by medicine. but indigenous peoples and we all are indigenous to this planet, but indigenous peoples in greece and spain and north africa and south america, central america, mesoamerica, north america had lo

we have directed the fda to cease enforcement. now they're back. how come? >> right. i don't know why that stance has changed. to be fair, this occurred under the previous administration but they were right to pull back on the leash of the fda and i shall ooh you that statement. i this i the current administration has let them off the leash a bit and needs to rein them back in. >> bill: there is a component, here on screen. the levels of this in your sanitizer was 160 parts per million, right? in wine you've got 229 and spirits 104 and fruit juice 230. why is this a danger or contaminant or something similar, aaron? >> that's a good question. even included on the fda's list recognized as safe for adding as a flavor to food and beverages. i'm not sure why. it doesn't make any sense to me. it is interesting that the dozens of other distilleries audited the fda is saying the same thing to them. it is a natural occurring component of wines, juices, foods. it doesn't make sense and come after something so arbitrary two years later. >> bill: we were talking about this repub

now this extraordinary to think that these institutions were approved by the fda and the dea, fda is over the dea for clinical trials because they satisfied several important criteria. one unlikely to do any harm, two being able to address a critical medical need, that's not currently being addressed by conventional medicine. and three, is it scalable? can it be brought in as a medicine at an affordable price? so indeed these benchmarks have been met, there is now up to 40 institutions that are currently doing clinical studies on psilocybin. and even in europe, i think there's around, next slide if we could, we have about 20 institutions in europe also. so this is a global movement, which is astonishing about this is the course of conclusions all steer towards the same end points that these are some of the most powerful psychoactive, and psychiatric medicines ever been discovered by medicine. but indigenous peoples and we all are indigenous to this planet, but indigenous peoples in greece and spain and north africa and south america, central america, mesoamerica, north america had lo

the fda are allowing those kids to be vaccinated. parents are about to send their kids back to school. should they be worried about this now? >> look, i don't think this is something that people need to be generally worried about. i think probably the incidence of this infection in the broader community is still very low. your risk of coming into contact with monkeypox is exceedingly low. outside of certain social networks where you see a higher case rate. but if we want to contain this, if we want to prevent this from becoming an endemic virus, we need to look more widely for it. the worst case scenario is we start testing more broadly and don't find it, that would be reassuring, but we should still do it. we could start to look for monkeypox in wastewater to see if it's spreading in communities and geographic locations where right now we don't think it's spreading but it could be. >> we don't know. on vaccines, we know there is a national shortage. there are two doses of this vaccine that are required. hhs and the fda said on thurs

our vaccine, named comirnaty, is now fda-approved for ages 12 and up. brought to you by pfizer and biontech. . >> o'donnell: finally tonight, we turn our focus to a ground-breaking photographer's decades-long passion to capture beauty wherever he could findita second look. here's cbs' nikki battiste. >> this is him. >> reporter: kwame brathwaite is legendary for his work behind the camera. the now-84-year-old photographer and activist popularized the 1960s "black is beautiful" movement. brathwaite's famous photos were celebrities. >> this was actually before i was born. >> reporter: but it's this body of work his son wants people to see, to remember. so he helped create this exhibit at the new york historical society, documenting how his dad helped change america's political and cultural landscape. >> "black is beautiful" was kind of at the foundation of his work and it's filled into the politics, the art, the media. >> reporter: brathwaite illuminated black women during a time they were expected to hide their real hair and wear long, straightuition. he

telemundo mediodÍa, la nueva dosis de refuerzo contra la variante Ómicron del covid-19 es aprobada por la fda, la fabrican pfizer y moderna y se empezarÁ a administrar en unos dÍas. el departamento de justicia le solicita al juez que por seguridad nacional rechace la peticiÓn de trump de nombrar a un supervisor especial que analice los papeles que se lleÓo a su residencia, el expresidente reacciona con ironÍa. el consumo de marihuana crece en estados unidos, una encuesta recoge que se fuma mÁs que los cigarrillos, casi la mitad de los encuestados dicen que la han probado alguna vez en su vida. >> la selecciÓn de fÚtbol rechaza el uso persistente de cantos homofÓbicos en partidos en mÉxico, la fifa ya ha sancionado al paÍs por estos cÁnticos en estadios el mundo recuerda hoy la muerte de la princesa diana de gales hace 25 aÑos en un accidente en parÍs donde se han depositado flores en el puente donde perdÓo la vida. ♪♪ (mÚsica) ♪♪ quÉ tal, cÓmo estÁn, gracias por acompaÑarnos, les saluda felicidad aveleyra, la fda acaba de aprobar el uso de emergencia de la nueva do

another one is behind the fda approved. joining me is the ceo and cofounder. the stock market in particular is not doing well, why did you decide now at the right time? >> we are delivering a huge unmet need. we are growing a new medicine class. the need that we started with mental health issues has gotten worse. we see an urgent need. doctors are prescribing, patients are raising their hand and the demand is there. it's the right term to deliver. this is a long-term story of a lasting medicine company, not a single point in time. now is the time to grow. emily: investors are back in your company. shares did not do so well today. why go for it now? guest: first a volatile day. we are not looking for any date in particular to see market movements, we think the story resonates with investors. they're going to be volatile days across the market. i am looking for the ability to grow into a lasting company. structure a deal that brought in $164 million independent of the redemption profile. the beauty is getting to partner with people who know how to grow large dis

scientists will now take it to the fda. if everything goes as predicted, it could be available for use by the fall 2023. crime-fighting cameras. the pros and cons. another bay area cities adding them to watch you drive. that is a sound no one wants to hear. what a bay area family just did feet from their sliding door. a snake expert is explaining why these rattlesnakes are coming with less moderate-to-severe eczema, why hide your skin if you can help heal your skin from within? dupixent helps keep you one step ahead of eczema with clearer skin and less itch. hide my skin? not me. serious allergic reactions can occur that can be severe. tell your doctor about new or worsening eye problems such as eye pain or vision changes, including blurred vision, joint aches and pain, or a parasitic infection. don't change or stop asthma medicines without talking to your doctor. ask your doctor about dupixent. in order for small businesses to thrive, without talking they need to be smart. efficient. agile. and that's never been more impor

and it is fda approved. joining me is the ceo and cofounder. we just heard crystal talking about how hard it is to go public right now. the spac market in particular not doing well. why did you decide now is the right time? >> we are delivering into a huge, unmet need. we founded this company almost a decade ago and we've been growing this new type of medicine class and have had to invent a lot of it. the need we started on which was people dealing with cognitive health issues and not having a full, can -- complete set of treatments, that has gotten worse over covid, dramatically worse. we see an urgent need and we are at a point in the business where we know we can scale our medicine products. we've done the work to show the fund metals are there. doctors are prescribing in patients are raising their hand. the demand is there, so it's the right time to deliver on our long-term vision. for us, this is a long term story of building a lasting medicine company. now's the time to grow. emily: there is inventor backing your company who has a number

a phosphor for avon time because they are spending a lot but they don't have drugs approved by the fda to generate any money. so those unprofitable companies that are supported by investors, those are the ones where innovation is happening. because the fda, the drug approval process is so expensive in many cases, they need a lot of money from investors and others to support their work. what happens is these larger companies like pfizer they come in and of in at the last minute when the drug is about to get approved and they will do the last bit to get it over the finish line and they can consider the money. one example of that is the pfizer vaccine. what we know as the pfizer vaccine was not developed by pfizer. it was developed by a german startup called biontech. we know the u.s. market, there are a lot of hurdles here. so to give up the right to your drug and we will sell it in the u.s. and the german companies that we don't have the resources so we will let you go ahead and do that. now we call it the pfizer vaccine but pfizer did not develop the vaccine. host: our guest with us un

um when the fda met and then the cdc met after that, in june, the fda really charged the drug companies with coming up with vaccine that would not only include the ancestral stream, but it would include something new, and that is what was currently circulating what is circulating now, so we knew that this was going to be coming and we knew that frankly, the fda had to make a decision before tomorrow because the cdc is meeting tomorrow to discuss how to really apply the vaccine. how boosters might be in containing a possible fall or winter search ? yeah i think that's the key question. you know, we don't have a tremendous amount of data in terms of effectiveness. i don't have any concerns about safety, but i do. wonder about how effective they are going to be, um, we know that the previous vaccines are doing a very good job in terms of preventing against hospitalization and death. where they really fall down is preventing people from getting infected and having mild to moderate disease. the hope is that with the addition of this coverage for b 8.4 point five it's going to make the vaccin

but it does again depend on what the fda says and we're talking about pfizer specifically. but moderna, potentially, not that far behind. i can tell you i visited these plants, i was at the pfizer plant, even going back to some of the original variants. they were -- they have been working on bivalent vaccines for other things in the past as well. we didn't need them because the original vaccine held up so well, so we'll see how much more of an improvement this new bivalent vaccine has and what the fda says about it. >> if there is anything you and i have bonded over over the last three years it is data. and so when it comes to this, how promising is the data so far? >> kaitlan, they look at this sort of data and they're doing it rapidly, they're trying to determine does the new vaccine, does it generate the same sort of neutralizing antibodies as previous vaccines and does it generate those antibodies against the new variants? so that's the sort of data they're looking at. ultimately the sort of data that everybody wants is to say, hey, how does this do in real world popula

still ahead here on our show, the fda has cleared new covid-19 boosters coming up. we're speaking with a doctor. >> about the future of covid-19 and how it will affect us here in the bay. plus, following up on the tragic death of a woman and an elderly care home. what we're learning the facility had drawn multiple complaints previously. that's straight ahead. after the break. >> a >> san mateo assisted living facility is under fire now after a woman died from drinking dishwashing liquid. she had been served and now more details are coming out about other complaints filed against this particular nursing home kron four's. rob nesbitt has the story. >> 3 residents were taken to the hospital at the in just a dishwashing liquid at the atria park senior living facility. the family of gertrude maxwell telling kron 4 that the 93 year-old died after having severe blisters in her mouth, throat and tpesophagus. it's unusual because there's 3 people that i know of involved. i spoke with elder abuse attorney, katherine stabbed or who has filed 2 lawsuits in the past against the

the fda say they are investigating. they have not made any recommendations about terror flower, -- terror flower -- revive super foods ceo did not respond to recent requests by abc7news. ama: new at 11:00, voters in kansas rejected a statewide ban on abortions, with historic turnout, voters were asked to remove a protected right to abortion. the procedure is currently legal up to 22 weeks in kansas. kansas became the first state in the nation to let voters weigh in on abortion since the u.s. supreme court overturned roe v. wade. dan: san francisco is celebrating transgender history month. mayor london breed took part today. we were there as the neighbor -- the mayor did walking tour of the trip cultural district. it was founded in 2017 and encompasses several blocks in the tenderloin neighborhood. san francisco became the first city in the country to recognize transgender history month. ama: let's get a dan: look at our weather. dan:dan: meteorologist sandhya patel is tracking that for us. sandhya: the weather looks fan

since the fda issued the e. u. a. on august 9th, we have shipped approximately 188,000 additional vials of vaccine, which represents up to 940,000 doses using the intradermal vaccination method covered by the eu a combined that comes to about 1.5 million doses already distributed and in the field. now on monday we launched the fourth phase of our national vaccine strategy, making the next 360,000 vials of vaccine available to states and jurisdictions for ordering and distribution. using the intradermal administration method. jurisdictions can administer up to 1.8 million doses of vaccines from these files taken together by the end of phase four, we will have provided enough files to states and jurisdictions to provide more than three million doses of vaccines, meaning we have supplied nearly enough vaccine to reach the entire at risk population. we've got more to do but this is an important step along the way. now as supply continues to increase steadily and we ship out thousands of doses daily. it's important that we

now the fda grants emergency use authorization if the fda grants emergency use authorization for this pfizer covid booster, you may be able to walk up to your pharmacy like the one behind us and get your shots, they're already excited to get their covid shots there, that new covid shot would also be available for everyone above the age of 12, which is different from previous covid boosters. i hope that answers your question a little bit more. >> it does. they're probably a little excited to see you, they're like ginger! >> shot or ginger conejero saab? >> thank you. >> catch the live interview with dr. rochelle walensky on the "today" show, she talks about the latest on the monkeypox health emergency as well. that's at 7:00, right after "today in the bay." >>> speaking of monkeypox, the virus is now being reported in all 50 states of the nation. yesterday wyoming became the last state to report a case of monkeypox. new york has the most infections and more than 2,700. so far, more than 14,000 cases have been reported nationwide. >>> happening today, marin county supervisors will vote

to do is make sure that every element of that vile is to perfection >> reporter: back in june, the fda asked both pfizer and moderna to develop shots targeting ba.5, which makes up most of the cases in the u.s >> well, it's certainly hoped that these new updated vaccines will provide improved protection against serious disease, disease serious enough to require hospitalization. >> reporter: because the process was so fast, human trials have not been completed. will you run human trials on this one >> human trials, for sure actually are -- just begun, so absolutely they're under way. >> reporter: health officials point out the annual flu vaccine is not tested on humans but covid mutates faster than the flu. it feels a little bit like whack-a-mole th this virus how difficult is it to keep pace with how quickly the virus is changing >> it's a very special disease. we launched the original product in nine months, and now we're actually converting from variants in 100 days or less. >> reporter: experts say this new shot could prevent a serious covid surge in the coming months. >> we have a

the fda say they are investigating. they have not made any recommendations about terror flower, -- terror flower -- revive super foods ceo did not respond to recent requests by abc7news. ama: new at 11:00, voters in kansas rejected a statewide ban on abortions, with historic turnout, voters were asked to remove a protected right to abortion. the procedure is currently legal up to 22 weeks in kansas. kansas became the first state in the nation to let voters weigh in on abortion since the u.s. supreme court overturned roe v. wade. dan: san francisco is celebrating transgender history month. mayor london breed took part today. we were there as the neighbor -- the mayor did walking tour of the trip cultural district. it was founded in 2017 and encompasses several blocks in the tenderloin neighborhood. san francisco became the first city in the country to recognize transgender history month. ama: let's get a dan: look at our weather. dan:dan: meteorologist sandhya patel is tracking that for us. sandhya: the weather looks fan

how important is the fda are emergency use authorization? it is important, the message about being able to now get that vaccine intradermally, rather than subcutaneously. you may have the same immune response and could theoretically use 1/5 of the vaccine. the cdc today did talk about some of the barriers in educating people how to actually administer the vaccine. and what needs to be done to make sure it is given appropriately. this is an important step forward in terms of fractionalizing how vaccine is supplied. as we have been reporting, there's not enough vaccine to meet demand. >> there's also confusion among some people of exactly how it spreads. that's another part of the messaging that needs to get refined so people understand. we've got to leave it there. thanks for your insight. >> thank you. >> a little league player gets hit in the head by a pitch. it's what happens next that has i am robert strickler. i've been involved in communications in the media for 45 years. i've been taking prevagen on a regular basis for at least eight y

. > >> the maker of the monkeypox vaccine is voicing concerns about the fda's decision to change how shots are given. on tuesday the fda commissioner said that administering the shot shot under the top layer of the skin instead of the traditional method requires only a fraction of the vaccine which would stretch the supply but in a letter, the vaccine maker questioned the decision. the neh new approach shows it may have a a negative impact on vaccine uptake and coverage. the fda commissioner defended the agency's decision saying the new new dosing regimen resulted in some side effects but they were manageable. >> this will increase the number number of total doses available up to five fold. >> the company is testing the strength of older vaccine batches and is hopeful that around 1 million doses that ared are stockpiled that are technically expired may still b. be usable. > >> the cdc is no longer recommeg longer recommending social distancing and quarantining to slow the spread of covid. they are also changing the testing policy. they say we should focus focus on reducing severe ill

cibinqo — fda approved. 100% steroid free. not an injection, cibinqo is a once-daily pill for adults who didn't respond to previous treatments. and cibinqo helps provide clearer skin and less itch. cibinqo can lower your ability to fight infections, including tb. before and during treatment, your doctor should check for infections and do blood tests. tell your doctor if you've had hepatitis b or c, have flu-like symptoms, or are prone to infections. do not take with medicines that prevent blood clots. serious, sometimes fatal infections, lymphoma, lung, skin and other cancers, serious heart-related events, and blood clots can happen. people 50 and older with heart disease risk factors have an increased risk of serious heart-related events or death with jak inhibitors. this is the moment. but we've only just begun. speak with your doctor about cibinqo today. an innovation from pfizer. meet google pixel 6a the smarter phone that can see in the dark with night sight fix your photos with magic eraser and photograph all skin tones

we have millions of treatments available, but because it's only been approved for smallpox, and the fda has not yet approved it for monkeypox, doctors who all tell me that it's very, very effective, it really helps people, doctors have to spend like two hours per patient filling out paperwork and jumping through hoops to get it authorized, and it can delay the medication by days. so we need the fda to grant an emergency use authorization. >> reporter: this is new video into our newsroom of a long line of people waiting for the monkeypox vaccine. this morning, the hospital reopened its walk-up clinic after the city received 10,000 more doses from the federal government. doses sf was supposed to receive last week. kaiser, ucsf will also give shots by appointments. 23,000 doses have been sent to san francisco over the past few weeks. according to "the new york times," the federal government is expected to issue an emergency declaration sometime today. that would allow doctors and nurses to stretch out the vaccine doses. so one dose could be split among five people. they do this by changing

credit to the fda, the commissioner of the fda and our leaders today. they have responded to what was a slow start to this crisis. today's response is a declaration. it is an important move. let me clarify why. there is something called the expanded access program, in which the fda, cdc, and making available something called t pox resort, something you and i talked about. it's a medication that has never been tested in human beings including in terms of fighting off a monkeypox infection. we have studies in animal data showing might be effective and we know that it's effective in. humans were taking a leap of faith, that this is likely to be effective with humans but we don't have that data. this is wives expanded use program is important so the fda and cdc can make it is available as possible, and can collect data as well so that we can have information to get it finally approved. that's why there is still some measure, but it's vastly more streamlined than it was two weeks ago. now you can get your community health center and more places outside the a

it shows the fda is quite agile. a lot of uncertainties. the only data we have for this specific vaccine so far is in mice. that's what is used for flu shots, updating them from year to year. this is a different virus. the hope is that it will reduce infections and transmission. but we just don't know that yet. >> the "new york times" is reporting about this that the fda will decide whether to authorize the new boosters without seeking a recommendation from the panel of outside experts, which is its normal procedure. what do you make of that? >> well, they are going to have a cdc advisory committee review. so that may be at least some external review. it is a bit surprising that they're not going to entertain the fda advisory committee input. >> yeah. you also wrote recently about something that i don't think gets enough attention, and why i was looking forward to speaking to you. it's about long covid. a recent study indicated that 1 in 8 people who had covid experience symptoms over many months. it's still a condition that is largely myst

the first ever fda medicine with her2 breast cancer.atients- what's that? a very new subtype of breast cancer. 50% of all invasive cancers fall into that. her2 is a receptor that sits on the outside of cancer cells and causes them to grow. 15% to 20% of breast cancer patients have an abundance of these receptors. they're her2 positive and usually treated with chemo and the drug herceptin. 60% of those do have an appreciable number but not enough to be her2-positive. these are the her2 lows and the drug herceptin doesn't work in them. all these can benefit from enhertu. it's the newly proven antibody chemo drug. it prolongs life and makes it harder for disease to progress in stage 4 her2 lows. this is a highly effective option for all metastatic patients about to find out they're her2-low and not her2-negative. >> for those diagnosed with metastatic breast cancer, should they be looking into this? >> absolutely. so all you need to do, you can find out with your doctor but you can look at your pathology report. you want to look at the immunohisto score. if it

they come specifically as the fda asked for those changes. many people are asking whether they should wait to get their new booster or if they should get a booster they're eligible for now. here is cdc director richelle walensky. >> i would say there's never a better time to get your booster if you're eligible. if you're over the age of 50 and haven't gotten that second booster, you can still go ahead and get it now. >> the fda is allowing for pfizer to submit far less data on the shot than it did for previous vaccines. doctors say that might have some people resistant to getting the new boosters. >> taking a live look outside this midday. looks a little clearer than it did earlier this morning in san francisco. kari has been monitoring the forecast for us. >> it has definitely cleared up out there. it was so foggy you couldn't even see the bay bridge. that's the way we've been starting out the past few mornings and that's what keeps those temperatures down. let's make our way inland as we look at dublin right now. we also had clouds here to

what you will want to hear from the fda. >>> this serious security flaw. the reason you may want to run an update on your laptop or ipad. >>> our team has been tweeting updates from watsonville all evening. twitter page, great resource for breaking news that we are following right now. >> at this late hour, they are scrambling for answers. federal investigators, trying to piece together what went wrong, as two small planes crashed into each other while trying to land at the watsonville airport. >> at least two people on board the planes have died third nbc bay area news's alyssa gord is at the crash site in watsonville. alyssa, what are you seeing out there right now? >> reporter: well, audrey, first of all, the airport is just behind us. behind the fence, right there. it's been a grim scene te in their trucks, who piled over, right in front of the wreckage of this airplane here, and appeared to extricate out what appeared to be a body out of the area of the airplane. there were tons of firefighters and investigators who had been here this evening. the moo

and you're learning the fda is now looking into stretching out those doses? >> reporter: well, whit, the cdc estimates about 1.6 million people are eligible to get the vaccine. each person needs two doses. so, the 1.1 million doses available right now aren't enough. so, the fda is looking into whether it can stretch the vaccine supply by pulling five doses out of a single vaccine v vial. whit, that would be a big difference. >> okay, janai, thank you. >>> and one more note on this. dr. ashish jha will be discussing the outbreak on "gma" fist thing tomorrow morning. >>> we move overseas now and wnba star brittney griner convicted today. a judge sentencing her to nine years in a penal colony. she's been detained for more than five months now, found guilty of intentionally smuggling vape cartridges of hashish oil into the country. president biden calling her sentence unacceptable. and the administration is again urging russia to accept its prisoner proposal. here's abc's senior white house correspondent mary bruce. >> reporter: this is the moment brittney griner

plus -- >> new guidance from the fda suggests three covid tests to catch asymptomatic cases. how that affects guidance as kids go back to schoo in order for small businesses to thrive, they need to be smart. efficient. agile. and that's never been more important than it is right now. so for a limited time, comcast business is introducing small business savings. call now to get powerful internet for just 39 dollars a month. with no contract. and a money back guarantee. all on the largest, fastest reliable network. from the company that powers more businesses than anyone else. call and start saving today. comcast business. powering possibilities. (swords clashing) -had enough? -no... arthritis. here. aspercreme arthritis. full prescription-strength? reduces inflammation? thank the gods. don't thank them too soon. kick pain in the aspercreme. >> big a better bay area. moving forward, finding solutions. this is abc7 news. dan: one year ago today, the taliban took over afghanistan. last august 15th, the taliban captured the capital as the u.s. withdrew quickly from the country and